Health Economics, Policy, and Outcomes Research 

Analysis of Predictive Value of Animal Repeated Dose Toxicity Study Results for Clinical Safety of US FDA-approved Anticancer Drugs between 2019 and 2023

G Choi, S Bae, KM Lim | Regulatory Toxicology and Pharmacology | 2026

A comparative analysis of biologics market dynamics in 12 countries: (Bio)similar and sustainability

Y Song, G Shin, G Choi, E Han, H Ou, SJ Bae | Frontiers in Pharmacology 16, 1659395 | 2025

Safe usage levels of aqueous Hippophae rhamnoides fruit extract in cosmetics estimated by threshold of toxicological concern

H Cho, YJ Koo, SH Lee, S Bae, J Choi, KM Lim | Regulatory Toxicology and Pharmacology | 2025

Combined Repeated-Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test of Calcium Nitrate Tetrahydrate in Sprague Dawley Rats

JW Eom, H Kang, JH Lee, SH Song, J Hong, S Bae, CJ Nam, KM Lim | Toxics 13(10), 835 | 2025

A genome-wide association study of stroke risk in Asian statin users: evidence from KoGES and UK Biobank

DH Lee, YA Park, JS Kim, Y Song, SJ Bae, J Yee, HS Gwak | Pharmacogenomics 26(10-12), 331-337 | 2025

Demand- Versus Supply-Side Policies in Market Penetration of Biosimilars: Which is More Effective?

G Shin, H Han, G Choi, D Lee, SJ Bae | BioDrugs 39(4), 635-644 | 2025

PhotoChem Reference Chemical Database for the Development of New Alternative Photosafety Test Methods

GY Lee, JH Hwang, JH Hong, S Bae, KM Lim | Toxics 13(7), 545 | 2025

Quantifying social contact dynamics in South Korea in the post-COVID-19 endemic phase

G Shin, SJ Bae | Journal of Infection and Public Health 18(6), 102725 | 2025

Unaware and unpowered: evaluating patient perceptions and preferences of biosimilars in South Korea

E Choi, G Shin, SJ Bae | Frontiers in Pharmacology 16, 1551451 | 2025

HCV self-testing: Bridging screening gaps and ensuring cost-effectiveness for both high-risk and universal populations

G Shin, BK Kim, SJ Bae, H Lee, SH Ahn | Clinical and Molecular Hepatology 31(2), e163 | 2024

Self-testing strategy to eliminate hepatitis C as per World Health Organization's goal

G Shin, BK Kim, SJ Bae, H Lee, SH Ahn | Clinical and Molecular Hepatology 31(1), 166 | 2024

Precision oncology clinical trials: a systematic review of phase II clinical trials with biomarker-driven, adaptive design

H Ha, HY Lee, JH Kim, DY Kim, HJ An, SJ Bae, H Park, JH Kang | Cancer Research and Treatment | 2024

Is the Availability of Biosimilar Adalimumab Associated with Budget Savings? A Difference-in-Difference Analysis of 14 Countries

H Woo, G Shin, D Lee, HY Kwon, SJ Bae | BioDrugs 38(1), 133-144 | 2024

Unveiling the Biosimilar Paradox of Oncologists' Perceptions and Hesitations in South Korea

G Shin, BS Kim, DY Kim, S Bae | BioDrugs 38(2), 301-311 | 2024

Impact and challenges of enactment for advanced regenerative medicine in South Korea

DS Kim, SJ Bae | Frontiers in Bioengineering and Biotechnology 10, 972865 | 2022

Price and prejudice? The value of chimeric antigen receptor (CAR) T-cell therapy

G Choi, G Shin, SJ Bae | Int J Environ Res Public Health 19(19), 12366 | 2022

The impact of payment scheme changes on medication adherence and persistence of patients diagnosed with depression in Korea

G Shin, B Jang, G Bae, HL Jeon, SJ Bae | Int J Environ Res Public Health 19(17), 11100 | 2022

Corporate social responsibility of pharmaceutical industry in Korea

G Bae, JH Ahn, KM Lim, SJ Bae | Frontiers in Pharmacology 13, 950669 | 2022

The value measurement of emerging therapeutics in renal cell carcinoma: ASCO value framework and ESMO-MCBS

H Ha, JH Kang, DY Kim, SJ Bae | BMC Health Services Research 22 | 2022

Korean guidelines for pharmacoeconomic evaluations: updates in the third version

EY Bae, J Hong, SJ Bae, S Hahn, H An, E Hwang, S Lee, T Lee | Applied Health Economics and Health Policy 20(4), 467-477 | 2022

How Sensitive is Sensitivity Analysis?: Evaluation of Pharmacoeconomic Submissions in Korea

S Bae, EY Bae, J Lee | Frontiers in Pharmacology | 2022

For whom the price escalates: high price and uncertain value of cancer drugs

G Shin, HY Kwon, SJ Bae | Int J Environ Res Public Health 19(7), 4204 | 2022

Projecting lifetime health outcomes and costs associated with the ambient fine particulate matter exposure among adult women in Korea

G Choi, Y Kim, G Shin, SJ Bae | Int J Environ Res Public Health 19(5), 2494 | 2022

How can we improve patients' access to new drugs under uncertainties? South Korea's experience with risk sharing arrangements

B Lee, EY Bae, SJ Bae, HJ Choi, KB Son, YS Lee, S Jang, TJ Lee | BMC Health Services Research 21(1), 967 | 2021

Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries

B Godman, M Haque, S Kumar, S Islam, J Charan, F Akter, A Kurdi, SJ Bae | Current Medical Research and Opinion 37(9), 1529-1545 | 2021

Regenerative Medicine in South Korea: bridging the gap between authorization and reimbursement

DS Kim, G Lee, H Cho, SJ Bae | Frontiers in Bioengineering and Biotechnology 9, 737504 | 2021

Should We Consider Value Frameworks for Cancer Drugs as Oncology's Landscape Evolves?

H Ha, SJ Bae, JH Kang | Journal of Korean Medical Science 36(29) | 2021

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems

B Godman, A Hill, S Simoens, G Selke, SJ Bae, et al. | Expert Review of Pharmacoeconomics & Outcomes Research 21(4), 527-540 | 2021

The current situation regarding long-acting insulin analogues including biosimilars among African, Asian, European, and South American countries

B Godman, M Haque, T Leong, E Allocati, S Kumar, S Islam, SJ Bae, et al. | Frontiers in Public Health 9, 671961 | 2021

Medication adherence and persistence of open-angle glaucoma patients in Korea: a retrospective study

Y Jang, D Jee, D Lee, NK Choi, SJ Bae | Int J Environ Res Public Health 18(8), 4106 | 2021

Value frameworks: adaptation of Korean versions of value frameworks for oncology

G Bae, SJ Bae, D Lee, J Han, DH Koo, DY Kim, HJ Kim, SY Oh, HY Lee | Int J Environ Res Public Health 18(6), 3139 | 2021

A meta-regression analysis of utility weights for breast cancer: the power of patients' experience

J Gong, J Han, D Lee, S Bae | Int J Environ Res Public Health 17(24), 9412 | 2020

Me-too validation study for in vitro skin irritation test with a reconstructed human epidermis model, KeraSkin™

J Han, S Kim, SH Lee, JS Kim, YJ Chang, TC Jeong, SJ Bae, et al. | Regulatory Toxicology and Pharmacology 117, 104725 | 2020

The burden of cervical cancer in Korea: a population-based study

J Kim, D Lee, KB Son, SJ Bae | Int J Environ Res Public Health 17(17), 6308 | 2020

Uptake of biosimilar infliximab in the UK, France, Japan, and Korea: budget savings or market expansion across countries?

Y Kim, HY Kwon, B Godman, E Moorkens, S Simoens, SJ Bae | Frontiers in Pharmacology 11, 970 | 2020

Are recently evaluated drugs more likely to receive positive reimbursement recommendations in South Korea?

JR Gong, D Lee, KM Lim, SJ Bae | Clinical Therapeutics 42(7), 1222-1233 | 2020

Modeling healthcare costs attributable to secondhand smoke exposure at home among South Korean children

J Park, SJ Bae | Int J Environ Res Public Health 17(12), 4496 | 2020

Do we consider to apply the value framework of cancer drugs to clinical practice and health insurance coverage in Korea?

DY Kim, H Ha, HY Lee, DH Koo, HS Han, SY Oh, SJ Bae, et al. | Journal of Clinical Oncology 38(15_suppl), e19391 | 2020

Marketing and pricing strategies of blockbuster drugs in the South Korean market: a 15-year retrospective cohort study for choline alfoscerate

J Park, SJ Bae, TJ Lee, KB Son | Frontiers in Pharmacology 11, 232 | 2020

Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea

I Choi, D Lee, SJ Bae | BMC Public Health | 2020

Utilization of oral anticoagulants in Korean nonvalvular atrial fibrillation patients

HY Song, KB Son, JY Shin, SJ Bae | International Journal of Clinical Pharmacy 41(6), 1434-1441 | 2019

Statistical analysis of the reproducibility and predictive capacity of MCTT HCE™ eye irritation test

SE Lim, D Lee, SJ Bae, KM Lim | Regulatory Toxicology and Pharmacology 107, 104430 | 2019

Evaluation of skin sensitization potential of chemicals by local lymph node assay using 5-bromo-2-deoxyuridine with flow cytometry

BI Han, JS Yi, SJ Seo, TS Kim, I Ahn, K Ko, JH Kim, SJ Bae, JK Lee | Regulatory Toxicology and Pharmacology 107, 104401 | 2019

Healthcare resource use and costs of diabetic macular oedema for patients with antivascular endothelial growth factor versus a dexamethasone intravitreal implant in Korea

HJ Cho, KS Choi, JY Lee, D Lee, NK Choi, YK Lee, SJ Bae | BMJ Open 9(9), e030930 | 2019

Does the patent linkage system prolong effective market exclusivity? Recent evidence from the Korea-US Free Trade Agreement in Korea

KB Son, SJ Bae, TJ Lee | International Journal of Health Services 49(2), 306-321 | 2019

Easy cuts, easy rebound: Drug expenditures with massive price cuts in Korea

HY Kwon, S Bae, S Choi, S Park, EK Lee, J Kim | Health Policy 123(4), 388-392 | 2019

Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study

KB Son, SJ Bae | BMJ Open 9(3), e026603 | 2019

Me-too validation study for in vitro eye irritation test with 3D-reconstructed human cornea epithelium, MCTT HCE™

SE Lim, SJ Ha, WH Jang, KM Jung, MS Jung, KW Yeo, TC Jeong | Toxicology in Vitro 55, 173-184 | 2019

Response to Letter to the Editor on "Evaluation of radioisotopic and non-radioisotopic versions of local lymph node assays for subcategorization of skin sensitizers"

KM Lee, SJ Bae | Regulatory Toxicology and Pharmacology 94, 325-329 | 2018

Mental stress from animal experiments: a survey with Korean researchers

M Kang, AR Han, D Kim, T Seidle, KM Lim, SJ Bae | Toxicological Research 34(1), 75-81 | 2018

Real-world prescribing patterns of long-acting benzodiazepine for elderly Koreans in 2013

SY Park, SJ Bae, JY Shin | International Journal of Clinical Pharmacology and Therapeutics 55(6), 472 | 2017

Modeling lifetime costs and health outcomes attributable to secondhand smoke exposure at home among Korean adult women

J Lee, AR Han, D Choi, KM Lim, SJ Bae | BMJ Open 7(5), e013292 | 2017

Evaluation of radioisotopic and non-radioisotopic versions of local lymph node assays for subcategorization of skin sensitizers compliant to UN GHS rev 4

S Ha, IY Ahn, D Kim, JK Lee, S Sohn, MS Jung, Y Heo, T Omori, SJ Bae | Regulatory Toxicology and Pharmacology 85, 124-131 | 2017

Prevalidation trial for a novel in vitro eye irritation test using the reconstructed human cornea-like epithelial model, MCTT HCE™

H Yang, D Kim, WH Jang, S An, SA Cho, MS Jung, JE Lee, KW Yeo | Toxicology in Vitro 39, 58-67 | 2017

Risk of Pneumonia Associated with the Use of ICS/LABA: A Retrospective Cohort Study in Korea

J Park, JY Shin, S Bae | J Health Tech Assess 5(2), 95-101 | 2017

Review of risk sharing arrangements in some developed countries: Focusing on type of contracts and management system

YS Lee, SJ Bae, BR Lee, KB Son, HJ Choi, EY Bae, S Jang, TJ Lee | J Health Tech Assess 5(1), 13-21 | 2017

Exploration and comparison of in vitro eye irritation tests with the ISO standard in vivo rabbit test for the evaluation of the ocular irritancy of contact lenses

JW Yun, Q Hailian, Y Na, BC Kang, JH Yoon, EY Cho, M Lee, D Kim | Toxicology in Vitro 37, 79-87 | 2016

Performance standard-based validation study for local lymph node assay: 5-bromo-2-deoxyuridine-flow cytometry method

I Ahn, TS Kim, ES Jung, JS Yi, WH Jang, KM Jung, M Park, MS Jung | Regulatory Toxicology and Pharmacology 80, 183-194 | 2016

Factors associated with potentially inappropriate medication use in elderly Koreans in an outpatient setting

DS Kim, HL Jeon, J Park, SJ Bae | Journal of the American Geriatrics Society 64(9), e21-e23 | 2016

Metabolomic analysis of amino acids and lipids in human hair altered by dyeing, perming and bleaching

KM Joo, AR Kim, SN Kim, BM Kim, HK Lee, SJ Bae, JH Lee, KM Lim | Experimental Dermatology 25(9) | 2016

Factors associated with the career preference of 6-year doctor of pharmacy (Pharm. D) students in Korea

AR Han, MH Gil, S Bae | Indian J Pharm Educ Res 50(3), 322-9 | 2016

Eight-year experience of using HTA in drug reimbursement: South Korea

EY Bae, JM Hong, HY Kwon, S Jang, HJ Lee, SJ Bae, BM Yang | Health Policy 120(6), 612-620 | 2016

Predictive capacity of a non-radioisotopic local lymph node assay using flow cytometry, LLNA: BrdU-FCM

D Kim, H Yang, WH Jang, KM Jung, M Park, JK Choi, MS Jung, EY Jeon | Journal of Pharmacological and Toxicological Methods 78, 76-84 | 2016

Appraisal of within- and between-laboratory reproducibility of non-radioisotopic local lymph node assay using flow cytometry, LLNA: BrdU-FCM

H Yang, J Na, WH Jang, MS Jung, JY Jeon, Y Heo, KW Yeo, JH Jo | Toxicology Letters 234(3), 172-179 | 2015

Same drugs, valued differently? Comparing comparators and methods used in reimbursement recommendations in Australia, Canada, and Korea

G Bae, EY Bae, SJ Bae | Health Policy 119(5), 577-587 | 2015

Suppression of skin inflammation in keratinocytes and acute/chronic disease models by caffeic acid phenethyl ester

KM Lim, SJ Bae, JE Koo, ES Kim, ON Bae, JY Lee | Archives of Dermatological Research 307(3), 219-227 | 2015

Relationship of ceramide-, and free fatty acid-cholesterol ratios in the stratum corneum with skin barrier function

KM Joo, JH Hwang, SJ Bae, DH Nahm, HS Park, YM Ye, KM Lim | Journal of Dermatological Science 77(1), 71-74 | 2015

Analysis of statistical methods currently used in toxicology journals

J Na, H Yang, SJ Bae, KM Lim | Toxicological Research 30(3), 185-191 | 2014

KeraSkin™-VM: A novel reconstructed human epidermis model for skin irritation tests

KM Jung, SH Lee, WH Jang, HS Jung, Y Heo, YH Park, SJ Bae, KM Lim | Toxicology in Vitro 28(5), 742-750 | 2014

Sourcing quality-of-life weights obtained from previous studies: Theory and reality in Korea

SJ Bae, EY Bae, SH Lim | The Patient - Patient-Centered Outcomes Research 7(2), 141-150 | 2014

Impact of high fat diet-induced obesity on the plasma levels of monoamine neurotransmitters in C57BL/6 mice

M Kim, SJ Bae, KM Lim | Biomolecules & Therapeutics 21(6), 476 | 2013

A cross-sectional study of factors related to gastrointestinal drug use in Korean adolescents

KE Lee, SJ Hwang, HS Gwak, BK Lee, SJ Bae, S Rhie | Archives of Pharmacal Research 36(10), 1238-1243 | 2013

Korean Guidelines for Pharmacoeconomic Evaluation (Second and Updated Version): Consensus and Compromise

SJ Bae, SO Lee, EY Bae, S Jang | Pharmacoeconomics 31(4), 257-267 | 2013

Lessons from generic promotion policies in other countries

DS Kim, S Bae, S Jang | Health Policy and Management 23(3), 210-223 | 2013

Incidence and short-term mortality from perforated peptic ulcer in Korea: a population-based study

SJ Bae, KN Shim, N Kim, JM Kang, DS Kim, KM Kim, YK Cho, SW Jung | Journal of Epidemiology 22(6), 508-516 | 2012

Incidence and 30-day mortality of peptic ulcer bleeding in Korea

SJ Bae, N Kim, JM Kang, DS Kim, KM Kim, YK Cho, JH Kim, SW Jung | European Journal of Gastroenterology & Hepatology 24(6), 675-682 | 2012

Prevalence of gastroesophageal reflux disease in Korea and associated health-care utilization: a national population-based study

KM Kim, YK Cho, SJ Bae, DS Kim, KN Shim, JH Kim, SW Jung, N Kim | Journal of Gastroenterology and Hepatology 27(4), 741-745 | 2012

Health-care data collecting, sharing, and using in Thailand, China mainland, South Korea, Taiwan, Japan, and Malaysia

SM Aljunid, S Srithamrongsawat, W Chen, SJ Bae, RF Pwu, S Ikeda, L Xu | Value in Health 15(1), S132-S138 | 2012

Pharmaceutical promotion, prior authorisation and the use of erectile dysfunction medications in the US Medicaid population

SJ Bae, MB Rosenthal | Journal of Management & Marketing in Healthcare 2(4), 384-400 | 2009

Patients with multiple chronic conditions do not receive lower quality of preventive care

SJ Bae, MB Rosenthal | Journal of General Internal Medicine 23(12), 1933-1939 | 2008

Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic Medicaid population

SJ Bae, AD Paltiel, AL Fuhlbrigge, ST Weiss, KM Kuntz | Value in Health 11(1), 110-118 | 2008

Cost-effectiveness of inhaled steroids in asthma: impact of effect on bone mineral density

AL Fuhlbrigge, SJ Bae, ST Weiss, KM Kuntz, AD Paltiel | Journal of Allergy and Clinical Immunology 117(2), 359-366 | 2006

Trade-offs between hip fracture mortality and oral corticosteroid usages among white men and women

SJ Bae, AD Paltiel, AL Fuhlbrigge, KM Kuntz | Society for Medical Decision Making | 2005